{"totalResults":12,"results":[{"description":"NCI\u2019s Center for Cancer Research, Neuro-Oncology Branch is advancing care and treatment for people with brain tumors through collaborative scientific workshops, research discoveries, and successful clinical trials.","title":"Advances in Brain Tumor Clinical Care and Research - National Cancer Institute","contentType":"cgvBlogPost","url":"https://www.cancer.gov/rare-brain-spine-tumor/blog/2020/brain-tumor-advances"},{"description":"Read a summary of the inaugural 2018 NCI-CONNECT Meeting to learn about rare brain and spine tumor treatment advances, clinical trials, and more disease and project information.","title":"Rare CNS Tumor Cancer Moonshot Meeting - National Cancer Institute","contentType":"cgvBlogPost","url":"https://www.cancer.gov/rare-brain-spine-tumor/blog/2018/2018-meeting"},{"description":"Darien shares how he lived with what he thought was an aggressive brain cancer for eight years. Then, he got an accurate low-grade rare tumor diagnosis and made a fresh start.","title":"PXA Tumor Survivor - National Cancer Institute","contentType":"cgvBlogPost","url":"https://www.cancer.gov/rare-brain-spine-tumor/blog/2019/pxa-survivor"},{"description":"Learn about brainstem and diffuse midline gliomas grades, features, causes, symptoms, who they affect, how and where they form, and treatments.","title":"Diffuse Midline Gliomas Diagnosis and Treatment - National Cancer Institute","contentType":"cgvArticle","url":"https://www.cancer.gov/rare-brain-spine-tumor/tumors/diffuse-midline-gliomas"},{"description":"Read a summary of the 2019 NCI-CONNECT and BTTC meetings to learn about the latest brain and spine tumor advances and clinical trials.","title":"Rare Brain and Spine Tumor Meeting - National Cancer Institute","contentType":"cgvBlogPost","url":"https://www.cancer.gov/rare-brain-spine-tumor/blog/2019/2019-meeting"},{"description":"Learn about gliosarcoma grades, features, causes, symptoms, who the tumors affect, how and where they form, and treatments.","title":"Gliosarcoma Diagnosis and Treatment - National Cancer Institute","contentType":"cgvArticle","url":"https://www.cancer.gov/rare-brain-spine-tumor/tumors/gliosarcoma"},{"description":"To help guide you through your brain tumor journey, patients, caregivers, doctors, and advocates share their advice.","title":"Advice from the Brain Tumor Community - National Cancer Institute","contentType":"cgvBlogPost","url":"https://www.cancer.gov/rare-brain-spine-tumor/blog/2020/brain-tumor-advice"},{"description":"The Histone Mutated Midline Glioma Workshop was held at NIH, on September 27, 2018, where neuro-oncology experts from around the world met to discuss histone mutated midline gliomas.","title":"Histone Mutated Midline Glioma Workshop Report - National Cancer Institute","contentType":"cgvBlogPost","url":"https://www.cancer.gov/rare-brain-spine-tumor/blog/2020/histone-mutated-glioma-workshop"},{"description":"Read how Dr. Brett Theeler is helping treat and educate patients with PXA and APXA tumors, which are among the rarest of rare brain and spine cancers.","title":"Neurologist Helps Provide Care to CNS Tumor Patients - National Cancer Institute","contentType":"cgvBlogPost","url":"https://www.cancer.gov/rare-brain-spine-tumor/blog/2019/pxa-apxa-research"},{"description":"Learn about pleomorphic xanthoastrocytoma (PXA) and anaplastic pleomorphic xanthoastrocytoma (APXA) tumor grades, features, causes, symptoms, who the tumors affect, how and where they form, and treatments.","title":"Pleomorphic Xanthoastrocytoma (PXA) and Anaplastic Pleomorphic Xanthoastocytoma (APXA) Diagnosis - National Cancer Institute","contentType":"cgvArticle","url":"https://www.cancer.gov/rare-brain-spine-tumor/tumors/pleomorphic-xanthroastrocytoma"}]}